Xiang Luo
Academic / Other · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Intra-arterial Recombinant Human Tenecteplase Tissue-type Plasminogen Activator (rhTNK-tPA) Thrombolysis for A Acute Ischemic Stroke, Medium Vessel Occlusion | Phase 2 / Phase 3 | 2025-12-30 |
| Not Yet Recruiting | Bovis Calculus Stativus Treat Acute Cerebral Ischemic Stroke With Impaired Consciousness Acute Ischemic Stroke AIS, Impaired Consciousness | Phase 2 / Phase 3 | 2025-12-15 |
| Completed | Heparin for RAO Post-Transradial Angiography in AIS Acute Ischemic Stroke | Phase 3 | 2025-08-04 |
| Recruiting | Efficacy and Safety of Early Combined Therapy With PCSK9 Inhibitors and Statins in Acute Ischemic Stroke Acute Ischemic Stroke | Phase 2 / Phase 3 | 2024-11-29 |
| Completed | Tirofiban After Successful MT Recanalization in AIS Acute Ischemic Stroke, Vessel Occlusion | Phase 2 / Phase 3 | 2024-04-09 |